Spironolactone Tablet, Film Coated
Product Images NDC 51655-153

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51655-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone, showing its steroidal backbone with associated functional groups including a lactone ring and a thioester substituent.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve chart comparing the probability of an outcome over time in months between two groups: spironolactone (n=822) and placebo (n=841). The vertical axis shows probability from 0 to 1, and the horizontal axis shows time from 0 to 48 months. The spironolactone group curve is higher than placebo, indicating different probabilities between groups, with a log-rank p-value less than 0.001.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot chart illustrating the hazard ratio (HR) and 95% confidence intervals (CI) for various subgroups related to spironolactone treatment versus placebo. The data split by categories like age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The x-axis ranges from 0.2 to 1.4 indicating spironolactone better to placebo better, respectively.*
FDA Label Image

Label (51655 153 52 Rev A 06 23 Nhc)

Label (51655 153 52   Rev A 06 23 Nhc)
Label for spironolactone tablets USP 100 mg, 30 tablets per package. The film-coated oral tablets are prescription-only. The label includes storage instructions, precautions to keep out of reach of children and to protect from light, and mentions the labeler as Northwind Health Company, LLC. The NDC is 51655-153.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.